| Authors: |
Hansen D; Department of Research Discovery Virology, Gilead Sciences, Inc., Foster City, California, USA., Hendricks MR; Department of Research Clinical Virology, Gilead Sciences, Inc., Foster City, California, USA., Chang S; Department of Research Clinical Virology, Gilead Sciences, Inc., Foster City, California, USA., Cai A; Department of Research Clinical Virology, Gilead Sciences, Inc., Foster City, California, USA., Perry JK; Department of Research Structural Biology and Chemistry, Gilead Sciences, Inc., Foster City, California, USA., Aeschbacher T; Department of Research Clinical Virology, Gilead Sciences, Inc., Foster City, California, USA., Martin R; Department of Research Clinical Virology, Gilead Sciences, Inc., Foster City, California, USA., Cihlar T; Department of Research Discovery Virology, Gilead Sciences, Inc., Foster City, California, USA.; Department of Research Clinical Virology, Gilead Sciences, Inc., Foster City, California, USA., Yant SR; Department of Research Discovery Virology, Gilead Sciences, Inc., Foster City, California, USA. |
